TP53 and B-cell chronic lymphocytic leukemia: APG-115 treatment restored p53 stabilization and its activity, which thus effectively inhibits cell proliferation, arrests cell cycle and induces cell apoptosis, and the combination with ABT-199 demonstrates a synergistic pro-apoptotic effect, suggesting a potential application of APG-115 in CLL therapy.